Pancreatic Cancer

Pancreatic cancer is one of the most aggressive forms of cancer with a relatively high chance of metastasis and a relatively low successrate of surgical resection.

Bladder cancer

Bladder cancers develop from the epithelial lining of the urinary bladder. cannabinoid receptors in the human bladder cancer cells could be targeted to treat the disease, but more research is needed in this field.

Lung cancer

Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. Although there are several subtypes of Lung cancer, in general cannabinoids such as THC and CBD appear to be therapeutic.

CB2

CB2 is primarily expressed in the immune cells and tissues of the body. Like CB1, CB2 is a G protein-coupled receptor which inhibits adenylyl cyclase and consequently lowers cAMP upon activation. This, in turn, regulates many second messenger pathways.

Prostate Cancer

Prostate cancer is the development of cancer in the prostate.

Leukemia

Leukemia cancers usually begin in the bone marrow and involves abnormal white blood cell production.

Glioblastoma

Glioblastoma is a malignant brain tumor originated in brain cells called astrocytes. Glioblastoma is one of the most promising targets for cannabinoid therapy.

Cervical cancer

Cervical cancer is a type of cancer that develops from the cervix.

Breast cancer

Breast cancers develop from breast tissue. cannabinoids have anti breast cancer properties involving inhibition of cancer growth and metastasis.

Bone cancer

Bone cancers result from primary tumor invasion to bone. cannabinoids can be used to relieve bone cancer pain through their anti-inflammatory properties and also they could be used to treat cancer itself.